Kiran Mazumdar-Shaw led the investment in Gytree.com in January 2023, emphasizing the need for female-first products in health. She highlighted the platform's mission to address the personalized health needs of women through technology, stating, 'Gytree.com fills an important gap in using technology to solve for personalised health needs of women through products and services.'
Kiran Mazumdar-Shaw established the Mazumdar-Shaw Scholarship Fund at Keck Graduate Institute in 2021, which provides scholarships to traditionally underserved students pursuing careers in community medicine.
Kiran Mazumdar-Shaw announced a strategic alliance with Biocon Biologics Limited in November 2022, which included Serum Life Sciences making an additional equity investment of $150 million into Biocon Biologics by converting a prior loan. This investment aims to enhance Biocon's position in the biosimilars market.
EN